COVID-19 vaccine developed by China's Sinopharm for emergency use, validated by WHO

2021-06-02

COVID-19 vaccine developed by China's Sinopharm for emergency use,validatedby WHO.


The World Health Organization (WHO) validated on May seventh the BBIBP-CorV COVID-19 vaccine developed by China's Sinopharm for emergency use.

This afternoon, WHO gave emergency use listing to Sinopharm Beijing's COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus at a press briefing.

This expands the list of vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine.


This article and photo original from China Daily Bilingual News.

It is a great honor that Bioendo’s endotoxin test solution (lysate reagent) contribute some effort to the quality control of endotoxin detection in the development and production of COVID-19 vaccine in China.

We hope peoples in all over the world will enjoy the peaceful time and good life.


Xiamen Bioendo Technology Co., Ltd.

Copyright © Xiamen Bioendo Technology Co., Ltd. All Rights Reserved

 

Chat now

Live Chat

Esteem Your specified requirements will help us make a complete solution and offer feedback to you quickly. Especially Purchase company Name/Tel/Whatsapp or Wechat for efficient communication.

home

products

company

contact